BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 30037330)

  • 1. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-876-5p represses the cell proliferation and invasion of colorectal cancer through suppressing YAP signalling via targeting RASAL2.
    Ren L; Zhang Z; Feng Y; Luo M; Hao Z
    Clin Exp Pharmacol Physiol; 2020 May; 47(5):867-876. PubMed ID: 31990059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
    Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
    J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EXOSC4 functions as a potential oncogene in development and progression of colorectal cancer.
    Pan Y; Tong JHM; Kang W; Lung RWM; Chak WP; Chung LY; Wu F; Li H; Yu J; Chan AWH; To KF
    Mol Carcinog; 2018 Dec; 57(12):1780-1791. PubMed ID: 30155936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
    Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.
    Yu M; Cui R; Huang Y; Luo Y; Qin S; Zhong M
    EBioMedicine; 2019 Oct; 48():264-276. PubMed ID: 31530502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CADM1 associates with Hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis.
    Ito T; Nakamura A; Tanaka I; Tsuboi Y; Morikawa T; Nakajima J; Takai D; Fukayama M; Sekido Y; Niki T; Matsubara D; Murakami Y
    Cancer Sci; 2019 Jul; 110(7):2284-2295. PubMed ID: 31069869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hippo pathway in colorectal cancer.
    Liang K; Zhou G; Zhang Q; Li J; Zhang C
    Saudi J Gastroenterol; 2014; 20(3):188-94. PubMed ID: 24976283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
    Qian F; Xiao J; Gai L; Zhu J
    Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
    Peng H; Pan X; Su Q; Zhu LS; Ma GD
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
    Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
    J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 14. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization.
    Chen C; Yuan W; Zhou Q; Shao B; Guo Y; Wang W; Yang S; Guo Y; Zhao L; Dang Q; Yang X; Wang G; Kang Q; Ji Z; Liu J; Sun Z
    Theranostics; 2021; 11(9):4298-4315. PubMed ID: 33754062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
    Zhong X; Lü M; Wan J; Zhou T; Qin B
    Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR-942-5p and releasing DLG2 via Hippo-YAP signaling.
    Li S; Yan G; Liu W; Li C; Wang X
    Mol Carcinog; 2020 Dec; 59(12):1323-1342. PubMed ID: 33128289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer.
    Sun Z; Ou C; Liu J; Chen C; Zhou Q; Yang S; Li G; Wang G; Song J; Li Z; Zhang Z; Yuan W; Li X
    Oncogene; 2019 Apr; 38(14):2627-2644. PubMed ID: 30531836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
    Feng S; Sun H; Zhu W
    Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
    Yan R; Liang ZW; Liu HS; Ge Y; An GY
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
    [No Abstract]   [Full Text] [Related]  

  • 20. IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation.
    Zhang W; Lu Y; Li X; Zhang J; Lin W; Zhang W; Zheng L; Li X
    J Exp Clin Cancer Res; 2019 Jul; 38(1):296. PubMed ID: 31288861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.